BNP Paribas Financial Markets
GOSS icon

BNP Paribas Financial Markets’s Gossamer Bio GOSS Stock Holding History

BNP Paribas Financial Markets’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Sell
73,693
-21,913
-23% -$6.12K ﹤0.01% 5353
2026
Q1 		$31.4K Buy
95,606
+6,117
+7% +$9.61K ﹤0.01% 4930
2025
Q4 		$277K Sell
89,489
-6,914
-7% -$19.7K ﹤0.01% 3905
2025
Q3 		$254K Buy
96,403
+79,286
+463% +$175K ﹤0.01% 3889
2025
Q2 		$21.1K Buy
17,117
+16,198
+1,763% +$17.7K ﹤0.01% 4579
2025
Q1 		$1.01K Sell
919
-35
-4% -$40 ﹤0.01% 5068
2024
Q4 		$863 Hold
954
– – ﹤0.01% 5104
2024
Q3 		$941 Hold
954
– – ﹤0.01% 3951
2024
Q2 		$859 Hold
954
– – ﹤0.01% 3874
2024
Q1 		$1.13K Sell
954
-81
-8% -$89 ﹤0.01% 3854
2023
Q4 		$944 Sell
1,035
-3,556
-77% -$2.63K ﹤0.01% 3854
2023
Q3 		$3.82K Sell
4,591
-77,083
-94% -$88.8K ﹤0.01% 3682
2023
Q2 		$98K Buy
81,674
+10,333
+14% +$12.9K ﹤0.01% 3258
2023
Q1 		$89.9K Sell
71,341
-436,503
-86% -$836K ﹤0.01% 3345
2022
Q4 		$1.1M Buy
507,844
+277,292
+120% +$2.28M ﹤0.01% 2105
2022
Q3 		$2.76M Buy
230,552
+213,753
+1,272% +$2.65M ﹤0.01% 1715
2022
Q2 		$141K Sell
16,799
-8,034
-32% -$62.3K ﹤0.01% 3228
2022
Q1 		$216K Sell
24,833
-6,130
-20% -$59.1K ﹤0.01% 3098
2021
Q4 		$350K Buy
30,963
+15,989
+107% +$190K ﹤0.01% 3183
2021
Q3 		$188K Buy
14,974
+7,378
+97% +$67.9K ﹤0.01% 3057
2021
Q2 		$61.7K Sell
7,596
-12,604
-62% -$109K ﹤0.01% 3189
2021
Q1 		$187K Buy
20,200
+12,582
+165% +$127K ﹤0.01% 3073
2020
Q4 		$73.7K Sell
7,618
-5,701
-43% -$56.2K ﹤0.01% 3366
2020
Q3 		$165K Buy
13,319
+8,045
+153% +$107K ﹤0.01% 2846
2020
Q2 		$68.6K Sell
5,274
-16,771
-76% -$211K ﹤0.01% 2919
2020
Q1 		$224K Buy
22,045
+15,844
+256% +$207K ﹤0.01% 2803
2019
Q4 		$96.9K Sell
6,201
-758
-11% -$15.3K ﹤0.01% 3307
2019
Q3 		$117K Buy
6,959
+5,087
+272% +$101K ﹤0.01% 3048
2019
Q2 		$41.5K Buy
+1,872
New +$35.8K ﹤0.01% 3532

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

BNP Paribas Financial Markets's GOSS Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Gossamer Bio (GOSS) stake by 23% in Q2 2026, selling an estimated $6.12K and leaving 73,693 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5353.

BNP Paribas Financial Markets first reported a position in GOSS in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.76M in Q3 2022. 155 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • BNP Paribas Financial Markets held 73,693 shares of Gossamer Bio worth $12.1K as of Q2 2026.
  • BNP Paribas Financial Markets sold 21,913 Gossamer Bio shares in Q2 2026, an estimated $6.12K.
  • Gossamer Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5353 holding.
  • BNP Paribas Financial Markets first reported a position in Gossamer Bio in Q2 2019 and has held it in 29 quarters since.
  • BNP Paribas Financial Markets's Gossamer Bio position peaked at $2.76M in Q3 2022.
  • 155 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.